Nanostructured carrier systems facilitating enhanced delivery of 8-(4-Amino-1 methylbutylamino)-6 methoxyquinoline: a narrative review

Abstract

8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline, an inhibitor of protozoan growth, presents an opportunity to explore nanostructured drug carriers to overcome these challenges. By encapsulating this compound in nanocarriers such as liposomes, dendrimers or polymeric nanoparticles, you can improve its solubility and protect it from degradation, thereby increasing circulation time and accumulation at the target site. This review will explore various nanostructured carriers for 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline, analyze their properties, and discuss how nanotechnology can enhance the efficacy of this antiparasitic agent. With the prevalence of parasitic diseases around the globe nanomedicine may provide the solution by enabling more effective delivery of compounds like 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline.